Fri, 31st Mar 2023 07:22
March 31 (Reuters) - Britain's Competition and Markets Authority (CMA) said on Friday that it would refer UnitedHealth Group's planned acquisition of healthcare technology firm EMIS for a Phase 2 investigation.
The watchdog said it had rejected remedies offered by U.S.-based UnitedHealth after deeming they did not go far enough in mitigating the potential competitive impact of the combination. (Reporting by Pablo Mayo Cerqueiro; editing by Jason Neely)
(Alliance News) - Emis Group PLC shares were cancelled from trading on AIM on Monday, after its takeover by UnitedHealth Group Inc subsidiary Optum He...
Emis Group PLC - Leeds, England-based healthcare software and services - Shares suspended from trading on AIM in London on Friday and expects to cance...
(Alliance News) - Emis Group PLC on Friday said the UK Competition & Markets Authority cleared its acquisition by UnitedHealth Group Inc to proceed.
(Sharecast News) - The Competition and Markets Authority said on Friday that it has cleared UnitedHealth's proposed £1.2bn takeover of UK ...
